DE60130667D1 - Eine kondensierte indolverbindung enthaltendes arzneimittel - Google Patents

Eine kondensierte indolverbindung enthaltendes arzneimittel

Info

Publication number
DE60130667D1
DE60130667D1 DE60130667T DE60130667T DE60130667D1 DE 60130667 D1 DE60130667 D1 DE 60130667D1 DE 60130667 T DE60130667 T DE 60130667T DE 60130667 T DE60130667 T DE 60130667T DE 60130667 D1 DE60130667 D1 DE 60130667D1
Authority
DE
Germany
Prior art keywords
concentrated
drug containing
indole compound
indole
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130667T
Other languages
English (en)
Other versions
DE60130667T2 (de
Inventor
Philip Christopher Buxton
Schie Dirk Marinus Van
Seona Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0019524A external-priority patent/GB0019524D0/en
Priority claimed from GB0118919A external-priority patent/GB0118919D0/en
Priority claimed from GB0119022A external-priority patent/GB0119022D0/en
Priority claimed from PCT/GB2001/003544 external-priority patent/WO2002011766A2/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE60130667D1 publication Critical patent/DE60130667D1/de
Application granted granted Critical
Publication of DE60130667T2 publication Critical patent/DE60130667T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60130667T 2000-08-08 2001-08-08 Eine kondensierte indolverbindung enthaltendes arzneimittel Expired - Lifetime DE60130667T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0019524 2000-08-08
GB0019524A GB0019524D0 (en) 2000-08-08 2000-08-08 Novel use
GB0118919A GB0118919D0 (en) 2001-08-02 2001-08-02 Novel use
GB0118919 2001-08-02
GB0119022 2001-08-03
GB0119022A GB0119022D0 (en) 2001-08-03 2001-08-03 Novel use
WOPCT/GB01/03544 2001-08-07
PCT/GB2001/003544 WO2002011766A2 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
PCT/GB2001/003590 WO2002011733A1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound

Publications (2)

Publication Number Publication Date
DE60130667D1 true DE60130667D1 (de) 2007-11-08
DE60130667T2 DE60130667T2 (de) 2008-07-17

Family

ID=27447871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130667T Expired - Lifetime DE60130667T2 (de) 2000-08-08 2001-08-08 Eine kondensierte indolverbindung enthaltendes arzneimittel

Country Status (8)

Country Link
EP (1) EP1313481B1 (de)
JP (1) JP2004505920A (de)
AU (2) AU2001276558B2 (de)
CA (1) CA2418921C (de)
DE (1) DE60130667T2 (de)
DK (1) DK1313481T3 (de)
ES (1) ES2294012T3 (de)
WO (1) WO2002011733A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1476136E (pt) * 2002-02-14 2006-10-31 Glaxo Group Ltd Composicao farmaceutica compreendendo n-((1-n-butil-4-piperidinil)metil)-3,4-di-hidro-2h-(1,3) oxazino (3,2-a) indole-10-carboxamida ou sal e processo de a obter compreendendo granulacao a seco.
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
FR3097215B1 (fr) 2019-06-13 2021-06-11 Sodimas Installation d’ascenseur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332830A1 (de) * 1982-09-16 1984-03-22 The Upjohn Co., 49001 Kalamazoo, Mich. Verwendung von benzodiazepinen zur bekaempfung oder bei der behandlung von panikzustaenden
NZ249565A (en) * 1992-03-12 1997-07-27 Smithkline Beecham Plc Hetring[1,2-a]indole-carboxy derivatives

Also Published As

Publication number Publication date
CA2418921C (en) 2010-10-26
EP1313481B1 (de) 2007-09-26
DK1313481T3 (da) 2008-01-28
DE60130667T2 (de) 2008-07-17
AU2001276558B2 (en) 2005-11-24
EP1313481A1 (de) 2003-05-28
ES2294012T3 (es) 2008-04-01
JP2004505920A (ja) 2004-02-26
CA2418921A1 (en) 2002-02-14
AU7655801A (en) 2002-02-18
WO2002011733A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
DE60037455D1 (de) Kinaseinhibitoren als arzneimittel
DK1219609T3 (da) Aromatiske nitrogenholdige 6-leddede ringforbindelser
NO20030418L (no) Nytt farmasöytisk preparat
NO20032236D0 (no) Laktamforbindelse
DE69908021T2 (de) Ziprasidonhaltige Arzneimittel
NO20071303L (no) Farmasoytiske preparater
EE200200097A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
PT1220856E (pt) Compostos farmaceuticamente activos
EE200200526A (et) Kapslid
MXPA03001425A (es) Compuestos farmaceuticos.
NO20024431D0 (no) Kapsler
NO20015149D0 (no) Nytt farmasöytisk preparat
NO20022606L (no) Farmasöytiske kombinasjoner
DE60109530D1 (de) Amorphe Mupirocin enthaltende Arzneimittel
NO20014926D0 (no) Farmasöytiske forbindelser
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
NO20015148L (no) Nytt farmasöytisk preparat
NO20032215D0 (no) Laktamforbindelse
EE200200073A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
NO20015104D0 (no) Nytt farmasöytisk preparat
DE60130667D1 (de) Eine kondensierte indolverbindung enthaltendes arzneimittel
NO20015105L (no) Nytt farmasöytisk preparat
ATE259233T1 (de) Lamivudin enthaltende arzneimittel
EE200300045A (et) Kristalne ravimaine
NO20021036D0 (no) Farmasöytisk preparat

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BUXTON, PHILIP CHRISTOPHER,, HARLOW C M19 5AW, GB

Inventor name: VAN SCHIE, DIRK MARINUS, HARLOW CM19 5AW, GB

Inventor name: THOMSON, SEONA, HARLOW CM19 5AW, GB

8364 No opposition during term of opposition